According to immunofluorescence, TF protein expression was 2.1 times higher in lungs with COVID-19, compared to lungs with ARDS without COVID-19 and 11 times higher than in control samples of healthy lungs. This evidence concerns the gene TF and acute respiratory distress syndrome.